We use cookies to provide you with a better service. Carry on browsing if you’re happy with this or read more about our cookie policy and privacy policy.
Patients with hypertrophic cardiomyopathy (HCM) being treated at Gloucestershire Hospitals now have the option to be treated with a new drug for the condition.
by Kate Tredgett